ACP-204 in Adults With Alzheimer's Disease Psychosis

Clinical trial NCT06159673 · RECRUITING

Trial details

NCT number: NCT06159673
Sponsor: ACADIA Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease Psychosis

Start date: 2023-11-14
Primary completion: 2028-01-01
Enrollment: 1074

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.